Anne Li
By screening millions of molecular targets, researchers have uncovered a tumor beacon detected by the immune cells of two patients with colorectal cancer. The screening technology, developed by Howard Hughes Medical Institute Investigator (HHMI) Christopher Garcia and colleagues after almost 20 years of basic molecular studies of the immune system, may ultimately lead to more effective immunotherapies, which harness the body’s immune system to fight cancer.
See original article at: https://www.sciencedaily.com/releases/2017/12/171221122603.htm
Post a comment